287 related articles for article (PubMed ID: 14512174)
1. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
[TBL] [Abstract][Full Text] [Related]
2. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Caniatti ML; Baldi E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2007 Dec; 192(1-2):219-25. PubMed ID: 17997167
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.
Morandi F; Venturi C; Rizzo R; Castellazzi M; Baldi E; Caniatti ML; Tola MR; Granieri E; Fainardi E; Uccelli A; Pistoia V
J Neuroimmune Pharmacol; 2013 Sep; 8(4):944-55. PubMed ID: 23625177
[TBL] [Abstract][Full Text] [Related]
6. Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules.
Fainardi E; Granieri E; Tola MR; Melchiorri L; Vaghi L; Rizzo R; Castellazzi M; Ceruti S; Paolino E; Baricordi OR
J Neuroimmunol; 2002 Dec; 133(1-2):151-9. PubMed ID: 12446018
[TBL] [Abstract][Full Text] [Related]
7. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis.
Fainardi E; Rizzo R; Castellazzi M; Stignani M; Granieri E; Baricordi OR
Hum Immunol; 2009 Dec; 70(12):981-7. PubMed ID: 19651179
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.
Filaci G; Contini P; Brenci S; Gazzola P; Lanza L; Scudeletti M; Indiveri F; Mancardi GL; Puppo F
Hum Immunol; 1997 Apr; 54(1):54-62. PubMed ID: 9154458
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA class I and class II antigens in patients with multiple sclerosis.
Ott M; Seidl C; Westhoff U; Stecker K; Seifried E; Fischer PA; Grosse-Wilde H
Tissue Antigens; 1998 Mar; 51(3):301-4. PubMed ID: 9550332
[TBL] [Abstract][Full Text] [Related]
10. Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
Rizzo R; Bortolotti D; Fredj NB; Rotola A; Cura F; Castellazzi M; Tamborino C; Seraceni S; Baldi E; Melchiorri L; Tola MR; Granieri E; Baricordi OR; Fainardi E
Hum Immunol; 2012 Nov; 73(11):1140-6. PubMed ID: 22922127
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis.
Fainardi E; Bortolotti D; Bolzani S; Castellazzi M; Tamborino C; Roversi G; Baldi E; Caniatti ML; Casetta I; Gentili V; Granieri E; Rizzo R;
Mult Scler; 2016 Feb; 22(2):245-9. PubMed ID: 26084349
[TBL] [Abstract][Full Text] [Related]
12. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.
Rizzo R; Pietrobon S; Mazzoni E; Bortolotti D; Martini F; Castellazzi M; Casetta I; Fainardi E; Di Luca D; Granieri E; Tognon M;
J Transl Med; 2016 Jul; 14(1):216. PubMed ID: 27443345
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
[TBL] [Abstract][Full Text] [Related]
14. Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study.
Adamashvili I; Minagar A; Gonzalez-Toledo E; Featherston L; Kelley RE
J Neuroinflammation; 2005 Jun; 2():13. PubMed ID: 15932635
[TBL] [Abstract][Full Text] [Related]
15. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal synthesis of soluble class I antigens in multiple sclerosis.
Alvarez-Cermeño JC; Villar LM; Nocito M; Bootello A; González-Porqué P
J Neuroimmunol; 1992 Jan; 36(1):77-9. PubMed ID: 1735771
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.
Contini C; Cultrera R; Seraceni S; Castellazzi M; Granieri E; Fainardi E
Mult Scler; 2004 Aug; 10(4):360-9. PubMed ID: 15327030
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
Alsahebfosoul F; Zavaran Hosseini A; Salehi R; Etemadifar M; Esmaeil N; Jamshidian A
Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):298-305. PubMed ID: 26546899
[TBL] [Abstract][Full Text] [Related]
19. Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study.
Minagar A; Adamashvili I; Kelley RE; Gonzalez-Toledo E; McLarty J; Smith SJ
J Neuroinflammation; 2007 Jul; 4():16. PubMed ID: 17601341
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.
Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Govoni V; Caniatti L; Paolino E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2004 Mar; 148(1-2):206-11. PubMed ID: 14975603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
